Aged
Cardiac Output, Low/*drug therapy/*economics/epidemiology
Cardiotonic Agents/*economics/*therapeutic use
Cost-Benefit Analysis/economics
Dobutamine/*economics/*therapeutic use
Double-Blind Method
Europe/epidemiology
Female
Follow-Up Studies
Heart Failure/*drug therapy/*economics/epidemiology
Humans
Hydrazones/*economics/*therapeutic use
Infusions, Intravenous
Length of Stay/economics
Life Expectancy
Male
Middle Aged
Patient Admission/economics
Pyridazines/*economics/*therapeutic use
Randomized Controlled Trials as Topic
Risk Factors
Sensitivity and Specificity
Severity of Illness Index
Survival Analysis
Treatment Outcome
